Portal de Periódicos da CAPES

Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions

2009; Wiley; Volume: 24; Issue: 12 Linguagem: Inglês

10.1002/mds.22652

1531-8257

Willi Gerschlager, Bastiaan R. Bloem,

Botulinum Toxin and Related Neurological Disorders

Movement DisordersVolume 24, Issue 12 p. 1858-1860 Letter Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions Willi Gerschlager MD, Corresponding Author Willi Gerschlager MD [email protected] Department of Neurology, Krankenhaus Hietzing, Neurologisches Zentrum Rosenhügel, Pavillon B, Vienna, AustriaDepartment of Neurology, Krankenhaus Hietzing, Neurologisches Zentrum Rosenhügel, Pavillon B, Vienna, AustriaSearch for more papers by this authorBastiaan R. Bloem MD, PhD, Bastiaan R. Bloem MD, PhD Department of Neurology, Donders Center for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Center, Nijmegen, The NetherlandsSearch for more papers by this author Willi Gerschlager MD, Corresponding Author Willi Gerschlager MD [email protected] Department of Neurology, Krankenhaus Hietzing, Neurologisches Zentrum Rosenhügel, Pavillon B, Vienna, AustriaDepartment of Neurology, Krankenhaus Hietzing, Neurologisches Zentrum Rosenhügel, Pavillon B, Vienna, AustriaSearch for more papers by this authorBastiaan R. Bloem MD, PhD, Bastiaan R. Bloem MD, PhD Department of Neurology, Donders Center for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Center, Nijmegen, The NetherlandsSearch for more papers by this author First published: 09 June 2009 https://doi.org/10.1002/mds.22652Citations: 15Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Gallagher DA,O'Sullivan SS,Evans AH,Lees AJ,Schrag A. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007; 22: 1757–1763. 2 Voon V,Potenza MN,Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol 2007; 20: 484–492. 3 Evans AH,Lawrence AD,Potts J,Appel S,Lees AJ. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 2005; 65: 1570–1574. 4 Houeto JL,Mesnage V,Mallet L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72: 701–707. 5 Ardouin C,Voon V,Worbe Y, et al. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 2006; 21: 1941–1946. 6 Nyholm D,Nilsson Remahl AI,Dizdar N, et al. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology 2005; 64: 216–223. 7 Voon V,Thomsen T,Miyasaki JM, et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 2007; 64: 212–216. 8 Weintraub D. Dopamine and impulse control disorders in Parkinson's disease. Ann Neurol 2008; 64( suppl): S93–S100. Citing Literature Volume24, Issue1215 September 2009Pages 1858-1860 ReferencesRelatedInformation